| European Case Law Identifier: | ECLI:EP:BA:2007:J001806.20071130 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 30 November 2007 | ||||||||
| Case number: | J 0018/06 | ||||||||
| Application number: | 03015590.7 | ||||||||
| IPC class: | A61K 38/48 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Use of the neurotoxic component of botulinum toxin for treating muscle spasm | ||||||||
| Applicant name: | ALLERGAN, INC. Third Party: Merz Pharma GmbH & Co. KGaA |
||||||||
| Opponent name: | - | ||||||||
| Board: | 3.1.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Suspension of grant proceedings (cancellation) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/j060018eu1.html
Date retrieved: 17 May 2021